• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化对茶碱谷浓度的影响:应用Child-Pugh 评分和 MELD 评分对器官损害的比较分析。

Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child-Pugh and MELD scores.

机构信息

Department of Pharmacy, Fukuoka City Hospital, Fukuoka City Hospital Organization, Local Incorporated Administrative Agency, Fukuoka, Japan.

Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Br J Clin Pharmacol. 2022 Aug;88(8):3819-3828. doi: 10.1111/bcp.15333. Epub 2022 Apr 6.

DOI:10.1111/bcp.15333
PMID:35338501
Abstract

AIMS

Theophylline clearance is known to be reduced in patients with chronic liver diseases (CLDs) such as chronic hepatitis (CH) and liver cirrhosis (LC). The Child-Pugh (CP) score is generally used for pharmacokinetic evaluation, whilst a model for end-stage liver disease (MELD) has not yet been fully evaluated. This study aimed to predict theophylline clearance in patients with LC classified based on CP and MELD scores by population pharmacokinetic (PPK) analysis.

METHODS

PPK analysis included 433 steady-state trough concentrations from 192 Japanese bronchial asthma patients with and without CLDs and was performed using NONMEM. The severity of LC was assessed by CP and MELD scores.

RESULTS

The final CP and MELD models which described apparent theophylline clearance (CL/F) were obtained. The CP model showed that the mean CL/F in patients without CLDs, CH patients and LC patients with CP class A, B and C was 0.0473, 0.0413, 0.0330, 0.0280 and 0.0209 L/h kg , respectively. The MELD model predicted that CL/F in patients without CLDs, CH patients and LC patients with MELD scores of <10, 10-14, 15-19, 20-24 and ≥25 was 0.0472, 0.0413, 0.0324, 0.0268, 0.0230, 0.0197 and 0.0155 L/h kg , respectively.

CONCLUSIONS

CL/F in various stages of LC was evaluated, and a change in CL/F was highly dependent on the severity of CLDs in both models. The MELD model provided a more accurate and precise description of theophylline clearance in LC than the CP model, which may be due to the wider dynamic range of the MELD score.

摘要

目的

已知茶碱清除率在慢性肝病(CLD)患者中降低,如慢性肝炎(CH)和肝硬化(LC)。Child-Pugh(CP)评分通常用于药代动力学评估,而终末期肝病模型(MELD)尚未得到充分评估。本研究旨在通过群体药代动力学(PPK)分析预测基于 CP 和 MELD 评分的 LC 患者的茶碱清除率。

方法

PPK 分析包括 192 例日本支气管哮喘患者和合并 CLD 患者的 433 个稳态谷浓度,采用 NONMEM 进行分析。LC 的严重程度通过 CP 和 MELD 评分评估。

结果

得到了描述茶碱表观清除率(CL/F)的最终 CP 和 MELD 模型。CP 模型显示,无 CLD 患者、CH 患者和 CP 分级 A、B 和 C 的 LC 患者的平均 CL/F 分别为 0.0473、0.0413、0.0330、0.0280 和 0.0209 L/h/kg。MELD 模型预测,无 CLD 患者、CH 患者和 MELD 评分<10、10-14、15-19、20-24 和≥25 的 LC 患者的 CL/F 分别为 0.0472、0.0413、0.0324、0.0268、0.0230、0.0197 和 0.0155 L/h/kg。

结论

评估了 LC 各个阶段的 CL/F,两种模型中 CL/F 的变化均高度依赖于 CLD 的严重程度。与 CP 模型相比,MELD 模型能更准确和精确地描述 LC 中的茶碱清除率,这可能是由于 MELD 评分的动态范围更广。

相似文献

1
Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child-Pugh and MELD scores.肝硬化对茶碱谷浓度的影响:应用Child-Pugh 评分和 MELD 评分对器官损害的比较分析。
Br J Clin Pharmacol. 2022 Aug;88(8):3819-3828. doi: 10.1111/bcp.15333. Epub 2022 Apr 6.
2
Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis.慢性肝炎与肝硬化患者茶碱清除率的差异。
Ther Drug Monit. 2020 Dec;42(6):829-834. doi: 10.1097/FTD.0000000000000787.
3
[Respective analysis of dead patients with cirrhosis by Child-Pugh score and model of end-stage liver disease score].[根据Child-Pugh评分和终末期肝病模型评分对肝硬化死亡患者进行的分别分析]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Oct;37(10):1021-5. doi: 10.3969/j.issn.1672-7347.2012.10.009.
4
MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis.MELD-GRAIL-Na 在韩国肝硬化患者中的死亡率预测优于 MELD。
Medicina (Kaunas). 2023 Mar 16;59(3):592. doi: 10.3390/medicina59030592.
5
CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.严重肝硬化患者的CYP3A活性与Child-Pugh评分及终末期肝病模型(MELD)评分相关。
Br J Clin Pharmacol. 2014 Jan;77(1):160-9. doi: 10.1111/bcp.12182.
6
Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver.印度肝硬化患者的吲哚菁绿清除试验(采用分光光度法)及其与终末期肝病模型(MELD)评分的相关性
Trop Gastroenterol. 2012 Apr-Jun;33(2):129-34. doi: 10.7869/tg.2012.30.
7
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores.评估肝硬化患者住院期间的预后:淋巴细胞/单核细胞比值与终末期肝病模型(MELD)及Child-Pugh评分的比较
Turk J Gastroenterol. 2018 May;29(3):308-315. doi: 10.5152/tjg.2018.17631.
8
The model for end-stage liver disease (MELD) predicts early and late outcomes of cardiovascular operations in patients with liver cirrhosis.终末期肝病模型(MELD)预测肝硬化患者心血管手术的早期和晚期结局。
Ann Thorac Surg. 2013 Nov;96(5):1672-8. doi: 10.1016/j.athoracsur.2013.06.007. Epub 2013 Aug 27.
9
Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.肝硬化患者的吲哚菁绿清除试验及终末期肝病模型评分
Hepatobiliary Pancreat Dis Int. 2009 Feb;8(1):46-9.
10
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis.肝细胞来源的生物标志物可预测 Child-Pugh 分级 A 酒精性肝硬化患者 2 年内的肝脏相关事件。
J Hepatol. 2023 Oct;79(4):910-923. doi: 10.1016/j.jhep.2023.05.025. Epub 2023 Jun 9.

引用本文的文献

1
Analysis of Factors Influencing Prognosis and Assessment of 60 Cases of Decompensated Cirrhotic Patients with Portal Hypertension.60例失代偿期肝硬化门静脉高压患者预后影响因素分析及评估
Int J Gen Med. 2024 Apr 18;17:1493-1498. doi: 10.2147/IJGM.S453107. eCollection 2024.